Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -1.89% | -13.33% | +28.71% |
03:52pm | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.71% | 81.64M | |
+6.60% | 111B | |
+11.60% | 106B | |
-12.57% | 22.24B | |
+0.03% | 21.25B | |
-4.59% | 18.97B | |
-35.21% | 18.52B | |
-10.62% | 16.81B | |
+37.66% | 12.54B | |
-25.37% | 8.09B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Citigroup Adjusts Price Target on Passage Bio to $10 From $15, Reiterates Buy Rating